These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. Regino CA; Torti SV; Ma R; Yap GP; Kreisel KA; Torti FM; Planalp RP; Brechbiel MW J Med Chem; 2005 Dec; 48(25):7993-9. PubMed ID: 16335923 [TBL] [Abstract][Full Text] [Related]
4. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Zhao R; Planalp RP; Ma R; Greene BT; Jones BT; Brechbiel MW; Torti FM; Torti SV Biochem Pharmacol; 2004 May; 67(9):1677-88. PubMed ID: 15081867 [TBL] [Abstract][Full Text] [Related]
5. Tumor cell cytotoxicity of a novel metal chelator. Torti SV; Torti FM; Whitman SP; Brechbiel MW; Park G; Planalp RP Blood; 1998 Aug; 92(4):1384-9. PubMed ID: 9694727 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
8. Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions. Planalp RP; Przyborowska AM; Park G; Ye N; Lu FH; Rogers RD; Broker GA; Torti SV; Brechbiel MW Biochem Soc Trans; 2002 Aug; 30(4):758-62. PubMed ID: 12196188 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of copper chelation agents as anti-angiogenic therapy. Camphausen K; Sproull M; Tantama S; Sankineni S; Scott T; Ménard C; Coleman CN; Brechbiel MW Bioorg Med Chem; 2003 Sep; 11(19):4287-93. PubMed ID: 12951159 [TBL] [Abstract][Full Text] [Related]
10. Novel chelating agents for potential clinical applications of copper. Ma D; Lu F; Overstreet T; Milenic DE; Brechbiel MW Nucl Med Biol; 2002 Jan; 29(1):91-105. PubMed ID: 11786280 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities. Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives. Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines. Onnis V; Cocco MT; Fadda R; Congiu C Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship studies of cytotoxic ester and ether anhydrovinblastine derivatives. Zhang HK; Shao Y; Ding H; Hu LH J Nat Prod; 2008 Oct; 71(10):1669-76. PubMed ID: 18771244 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives. Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers. Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903 [TBL] [Abstract][Full Text] [Related]
17. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity. Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4. Tsou HR; Liu X; Birnberg G; Kaplan J; Otteng M; Tran T; Kutterer K; Tang Z; Suayan R; Zask A; Ravi M; Bretz A; Grillo M; McGinnis JP; Rabindran SK; Ayral-Kaloustian S; Mansour TS J Med Chem; 2009 Apr; 52(8):2289-310. PubMed ID: 19317452 [TBL] [Abstract][Full Text] [Related]
19. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues. Congiu C; Cocco MT; Onnis V Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]